Finance

Beta
Lists
688278:SHA
Xiamen Amoytop Biotech Co Ltd
CN¥56.55
+2.67%
(+1.47) 1D
May 29, 3:00:05 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688278...
Open
CN¥55.46
High
CN¥57.38
Low
CN¥55.01
Mkt. cap
22.73B
Avg. vol.
3.38M
Volume
3.18M
Dividend
1.10%
Quarterly dividend
CN¥0.16
Ex-dividend date
May 29, 2026
P/E ratio
22.90
52-wk high
CN¥93.52
52-wk low
CN¥54.54
EPS
CN¥2.47
No. of employees
4K
Open
CN¥55.46
High
CN¥57.38
Low
CN¥55.01
Mkt. cap
22.73B
Avg. vol.
3.38M
Volume
3.18M
Dividend
1.10%
Quarterly dividend
CN¥0.16
Ex-dividend date
May 29, 2026
P/E ratio
22.90
52-wk high
CN¥93.52
52-wk low
CN¥54.54
EPS
CN¥2.47
No. of employees
4K
News stories
From sources across the web
About Xiamen Amoytop Biotech Co Ltd
CEO-
Employees3.64K
FoundedAug 7, 1996
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
837.27M
968.93M
1.22B
797.79M
Cost of goods sold
60.90M
77.67M
75.46M
84.14M
Cost of revenue
60.90M
77.67M
75.46M
84.14M
Research and development expenses
106.82M
105.76M
108.69M
93.64M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
393.21M
507.38M
568.29M
420.50M
Operating expense
507.88M
601.16M
702.25M
517.13M
Total operating expenses
568.78M
678.83M
777.71M
601.27M
Operating income
268.49M
290.11M
438.31M
196.53M
Other non operating income
-83.44K
-174.24K
-8.36K
-397.83K
EBT including unusual items
267.06M
254.73M
444.38M
179.04M
EBT excluding unusual items
269.77M
290.62M
441.89M
198.00M
Income tax expense
21.29M
16.50M
79.26M
14.55M
Effective tax rate
7.97%
6.48%
17.84%
8.12%
Other operating expenses
8.06M
-12.89M
25.22M
3.57M
Net income
245.77M
238.23M
365.11M
164.49M
Net profit margin
29.35%
24.59%
30.03%
20.62%
Earnings per share
0.59
0.60
0.96
-
Interest and investment income
1.46M
1.24M
4.63M
2.56M
Interest expense
-262.27K
-384.44K
-660.14K
-686.79K
Net interest expenses
1.19M
853.64K
3.97M
1.88M
Depreciation and amortization charges
-
-
-
-
EBITDA
289.86M
306.99M
466.76M
224.97M
Gain or loss from assets sale
-21.30K
21.30K
987.25K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more